Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases

Keziah Cooka Analysis Group, Inc., Menlo Park, CA, USA

Deepshekhar Guptaa Analysis Group, Inc., Menlo Park, CA, USA

Yunjuan Liua Analysis Group, Inc., Menlo Park, CA, USA

Chris Miller-Rosalesa Analysis Group, Inc., Menlo Park, CA, USACorrespondence[email protected]

https://orcid.org/0000-0003-4430-5968

Fangzhou Weia Analysis Group, Inc., Menlo Park, CA, USA

Edward Tuttlea Analysis Group, Inc., Menlo Park, CA, USA

Steven C. Katzb TriSalus Life Sciences, Inc, Westminster, CO, USA;c Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI, USA

Richard Marshakb TriSalus Life Sciences, Inc, Westminster, CO, USA

Alexander Y. Kimb TriSalus Life Sciences, Inc, Westminster, CO, USA

show all

Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases

TriNav_CMRO_Supplemental File.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases

TriNav_CMRO_Supplemental File.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date